Regístrese
metricas
covid
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Sustained virological response at week 12 after interferon-free therapy as crite...
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Brief report
Sustained virological response at week 12 after interferon-free therapy as criterion for HCV cure definition: Validation in a real-life cohort of HIV-coinfected patients
Validación de la respuesta viral sostenida en la semana 12 tras tratamiento con pautas libres de interferón para la confirmación de la curación de la infección por VHC en una cohorte de pacientes con coinfección por VIH
Lourdes Domínguez-Domíngueza,
Corresponding author
lourdes.dd@outlook.com

Corresponding author.
, María Lagardea, Otilia Bisbala, Mariano Matarranza,b, Rafael Rubioa, Federico Pulidoa
a HIV Unit, Internal Medicine Department, Biomedical Research Institute Imas12, Hospital Universitario 12 de Octubre, Madrid, Spain
b Servicio de Medicina Interna, Hospital Infanta Leonor, Madrid, Spain
Read
2716
Times
was read the article
463
Total PDF
2253
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2019.07.009
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 22 1 23
2024 October 45 3 48
2024 September 53 12 65
2024 August 65 7 72
2024 July 31 6 37
2024 June 34 5 39
2024 May 36 2 38
2024 April 35 6 41
2024 March 40 2 42
2024 February 57 3 60
2024 January 50 2 52
2023 December 36 6 42
2023 November 36 4 40
2023 October 55 4 59
2023 September 32 3 35
2023 August 23 3 26
2023 July 37 1 38
2023 June 41 3 44
2023 May 61 7 68
2023 April 38 2 40
2023 March 29 1 30
2023 February 18 6 24
2023 January 35 6 41
2022 December 39 8 47
2022 November 78 14 92
2022 October 82 12 94
2022 September 75 14 89
2022 August 78 15 93
2022 July 32 10 42
2022 June 40 12 52
2022 May 37 12 49
2022 April 122 20 142
2022 March 83 15 98
2022 February 96 10 106
2022 January 49 14 63
2021 December 47 24 71
2021 November 49 17 66
2021 October 56 17 73
2021 September 34 13 47
2021 August 60 14 74
2021 July 30 18 48
2021 June 24 12 36
2021 May 22 10 32
2021 April 41 14 55
2021 March 20 7 27
2021 February 27 9 36
2021 January 20 9 29
2020 December 17 12 29
2020 November 1 2 3
2020 October 4 0 4
2020 September 31 2 33
2020 August 4 3 7
2020 July 3 2 5
2020 June 43 27 70
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos